Yasuharu Tabara

ORCID: 0000-0003-4505-7951
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiovascular Health and Disease Prevention
  • Genetic Associations and Epidemiology
  • Blood Pressure and Hypertension Studies
  • Adipokines, Inflammation, and Metabolic Diseases
  • Nutrition and Health in Aging
  • Heart Rate Variability and Autonomic Control
  • Nutritional Studies and Diet
  • Obstructive Sleep Apnea Research
  • Adipose Tissue and Metabolism
  • Liver Disease Diagnosis and Treatment
  • Sleep and related disorders
  • Regulation of Appetite and Obesity
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Metabolomics and Mass Spectrometry Studies
  • Body Composition Measurement Techniques
  • Cardiovascular Syncope and Autonomic Disorders
  • Cardiovascular Disease and Adiposity
  • Frailty in Older Adults
  • Glaucoma and retinal disorders
  • Cerebrovascular and Carotid Artery Diseases
  • Diet, Metabolism, and Disease
  • Hormonal Regulation and Hypertension
  • Cancer-related molecular mechanisms research
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Retinal Imaging and Analysis

Kyoto University
2016-2025

University of Shizuoka
2021-2025

GTx (United States)
2008-2025

Center for Genomic Science
2017-2025

Shiga University of Medical Science
2010-2023

Center for Rheumatology
2021

Tokushima University
2021

Teikyo University
2021

Shizuoka General Hospital
2020-2021

Taipei Veterans General Hospital
2021

Norihiro Kato Marie Loh Fumihiko Takeuchi Niek Verweij Xu Wang and 95 more Weihua Zhang Tanika N Kelly Danish Saleheen Benjamin Lehne Irene Mateo Leach Alexander Drong James Abbott Simone Wahl Sian-Tsung Tan William R. Scott Gianluca Campanella Marc Chadeau‐Hyam Uzma Afzal Tarunveer S. Ahluwalia Marc Jan Bonder Peng Chen Abbas Dehghan Todd L. Edwards Tõnu Esko Min Jin Go Sarah E. Harris Jaana Hartiala Silva Kasela Anuradhani Kasturiratne Chiea Chuen Khor Marcus E. Kleber Huaixing Li Zuan Yu Mok Masahiro Nakatochi Nur Sabrina Sapari Richa Saxena Alexandre F.R. Stewart Lisette Stolk Yasuharu Tabara Ai Ling Teh Ying Wu Jer-Yuarn Wu Yi Zhang Imke Aits Alexessander Couto Alves Shikta Das Rajkumar Dorajoo Jemma C Hopewell Yun Kyoung Kim Robert W Koivula Jian’an Luan Leo‐Pekka Lyytikäinen Quang N Nguyen Mark A. Pereira Iris Postmus Olli T Raitakari Molly Scannell Bryan Robert A. Scott Rossella Sorice Vinicius Tragante Michela Traglia Jon White Ken Yamamoto Yonghong Zhang Linda S. Adair Alauddin Ahmed Koichi Akiyama Rasheed Asif Tin Aung Inês Barroso Andrew Bjonnes Timothy R. Braun Hui Cai Li-Ching Chang Chien‐Hsiun Chen Ching‐Yu Cheng Yap Seng Chong Rory Collins Regina Courtney Gail Davies Graciela Delgado Loi D. Pieter A. Doevendans Ron T. Gansevoort Yu-Tang Gao Tanja B. Grammer Niels Grarup Jagvir Grewal Dongfeng Gu Gurpreet S Wander Anna-Liisa Hartikainen Stanley L. Hazen Jing He Chew‐Kiat Heng James E. Hixson Albert Hofman Chris Hsu Wei Huang Lise Lotte N. Husemoen Joo‐Yeon Hwang

10.1038/ng.3405 article EN Nature Genetics 2015-09-21

There have been several clinical studies examining the factors associated with cardiovascular disease (CVD) in patients primary aldosteronism (PA); however, their results left it unclear whether CVD is affected by plasma aldosterone concentration or hypokalemia. We assessed PA database established multicenter JPAS (Japan Primary Aldosteronism Study) and compared prevalence of among that age-, sex-, blood pressure-matched essential hypertension participants a general population cohort. also...

10.1161/hypertensionaha.117.10263 article EN Hypertension 2018-01-22
Ken Suzuki Konstantinos Hatzikotoulas Lorraine Southam Henry J. Taylor Xianyong Yin and 95 more Kimberly Lorenz Ravi Mandla Alicia Huerta-Chagoya Giorgio Melloni Stavroula Kanoni Nigel W. Rayner Ozvan Bocher Ana Luiza Arruda Kyuto Sonehara Shinichi Namba Simon S. K. Lee Michael Preuß Lauren E. Petty Philip Schroeder Brett Vanderwerff Mart Kals Fiona Bragg Kuang Lin Xiuqing Guo Weihua Zhang Jie Yao Young Jin Kim Mariaelisa Graff Fumihiko Takeuchi Jana Nano Amel Lamri Masahiro Nakatochi Sanghoon Moon Robert A. Scott James P. Cook Jung‐Jin Lee Ian Pan Daniel Taliun Esteban J. Parra Jin Fang Chai Lawrence F. Bielak Yasuharu Tabara Yang Hai Guðmar Þorleifsson Niels Grarup Tamar Sofer Matthias Wuttke Chloé Sarnowski Christian Gieger Darryl Nousome Stella Trompet Soo‐Heon Kwak Jirong Long Meng Sun Tong Lin Wei‐Min Chen Suraj S. Nongmaithem Raymond Noordam Victor Lim Claudia H.T. Tam Yoonjung Yoonie Joo Chien-Hsiun Chen Laura M. Raffield Bram P. Prins Aude Nicolas Lisa R. Yanek Guanjie Chen Jennifer A. Brody Edmond K. Kabagambe Ping An Anny H. Xiang Hyeok Sun Choi Brian E. Cade Jingyi Tan K. Alaine Broadaway Alice Williamson Zoha Kamali Jinrui Cui Manonanthini Thangam Linda S. Adair Adebowale Adeyemo Carlos A. Aguilar‐Salinas Tarunveer S. Ahluwalia Sonia S. Anand Alain G. Bertoni Jette Bork‐Jensen Ivan Brandslund Thomas A. Buchanan Charles Burant Adam S. Butterworth Mickaël Canouil Juliana C.N. Chan Li-Ching Chang Miao-Li Chee Ji Chen Shyh‐Huei Chen Yuan‐Tsong Chen Zhengming Chen Lee‐Ming Chuang Mary Cushman

Abstract Type 2 diabetes (T2D) is a heterogeneous disease that develops through diverse pathophysiological processes 1,2 and molecular mechanisms are often specific to cell type 3,4 . Here, characterize the genetic contribution these across ancestry groups, we aggregate genome-wide association study data from 2,535,601 individuals (39.7% not of European ancestry), including 428,452 cases T2D. We identify 1,289 independent signals at significance ( P < 5 × 10 −8 ) map 611 loci, which 145...

10.1038/s41586-024-07019-6 article EN cc-by Nature 2024-02-19

Abstract Perivascular space (PVS) burden is an emerging, poorly understood, magnetic resonance imaging marker of cerebral small vessel disease, a leading cause stroke and dementia. Genome-wide association studies in up to 40,095 participants (18 population-based cohorts, 66.3 ± 8.6 yr, 96.9% European ancestry) revealed 24 genome-wide significant PVS risk loci, mainly the white matter. These were associated with matter already young adults ( N = 1,748; 22.1 2.3 yr) enriched early-onset...

10.1038/s41591-023-02268-w article EN cc-by Nature Medicine 2023-04-01

We scanned throughout chromosome 21 to assess genetic associations with late-onset Alzheimer disease (AD) using 374 Japanese patients and 375 population-based controls, because trisomy is known be associated early deposition of beta-amyloid (Abeta) in the brain. Among 417 markers spanning 33 Mb, 22 showed either allele or genotype frequency (P < 0.05). Logistic regression analysis age, sex apolipoprotein E (APOE)-epsilon4 dose supported risk 17 markers, which eight were linked SAMSN1, PRSS7,...

10.1093/hmg/ddl437 article EN cc-by-nc Human Molecular Genetics 2006-11-29

OBJECTIVE—Resistin, secreted from adipocytes, causes insulin resistance in rodents. We previously reported that the G/G genotype of a resistin gene promoter single nucleotide polymorphism (SNP) at −420 increases type 2 diabetes susceptibility by enhancing activity. report here on relation between plasma and either SNP or factors related to resistance. RESEARCH DESIGN AND METHODS—We cross-sectionally analyzed 2,078 community-dwelling Japanese subjects attending yearly medical checkup. The was...

10.2337/dc06-1936 article EN Diabetes Care 2007-05-25

The present study was conducted to confirm possible associations between candidate genes from genome-wide association studies and type 2 diabetes in Japanese diabetic patients a community-based general population. A total of 11 previously reported single-nucleotide polymorphisms (SNPs) the TCF7L2, CDKAL1, HHEX, IGF2BP2, CDKN2A/B, SLC30A8, KCNJ11 were analyzed.Candidate SNPs genotyped 506 402 control subjects meta-analyzed with six previous patients. Associations fasting plasma insulin levels...

10.2337/db07-1785 article EN cc-by-nc-nd Diabetes 2008-11-26

Objective Takayasu arteritis (TAK) is a systemic vasculitis affecting large arteries and branches of the aorta. Ulcerative colitis (UC) prevalent autoimmune colitis. Since TAK UC share HLA–B*52:01 IL12B as genetic determinants, since there are case reports co‐occurrence these diseases, we hypothesized that common complication TAK. We undertook this study to perform large‐scale analysis TAK, both evaluate prevalence concurrent cases identify estimate susceptibility genes shared between 2...

10.1002/art.39157 article EN Arthritis & Rheumatology 2015-04-30

Hyperglycemia is a risk factor for sarcopenia when comparing individuals with and without diabetes. However, no studies have investigated whether the findings could be extrapolated to patients diabetes relatively higher glycemic levels. Here, we aimed clarify control was associated in type 2 diabetes.Study participants consisted of (n = 746, average age 69.9 years) an older general population 2,067, 68.2 years). Sarcopenia defined as weak grip strength or slow usual gait speed low skeletal...

10.1111/jdi.13070 article EN cc-by Journal of Diabetes Investigation 2019-05-10

Profiles of sequence variants that influence gene transcription are very important for understanding mechanisms affect phenotypic variation and disease susceptibility. Using genotypes at 1.4 million SNPs a comprehensive transcriptional profile 15,454 coding genes 6,113 lincRNA obtained from peripheral blood cells 298 Japanese individuals, we mapped expression quantitative trait loci (eQTLs). We identified 3,804 cis-eQTLs (within 500 kb target genes) 165 trans-eQTLs (>500 away or on different...

10.1371/journal.pone.0100924 article EN cc-by PLoS ONE 2014-06-23
Fumihiko Takeuchi Masato Akiyama Nana Matoba Tomohiro Katsuya Masahiro Nakatochi and 95 more Yasuharu Tabara Akira Narita Woei‐Yuh Saw Sanghoon Moon Cassandra N. Spracklen Jin Fang Chai Young‐Jin Kim Liang Zhang Chaolong Wang Huaixing Li Honglan Li Jer‐Yuarn Wu Rajkumar Dorajoo Jovia L. Nierenberg Ya Xing Wang Jing He Derrick Bennett Atsushi Takahashi Yukihide Momozawa Makoto Hirata Koichi Matsuda Hiromi Rakugi Eitaro Nakashima Masato Isono Matsuyuki Shirota Atsushi Hozawa Sahoko Ichihara Tatsuaki Matsubara Ken Yamamoto Katsuhiko Kohara Michiya Igase Sohee Han Penny Gordon‐Larsen Wei Huang Sang Lee Linda S. Adair Mi Yeong Hwang Juyoung Lee Miao Li Chee Charumathi Sabanayagam Wanting Zhao Jianjun Liu Dermot F. Reilly Liang Sun Shaofeng Huo Todd L. Edwards Jirong Long Li-Ching Chang Chien-Hsiun Chen Jian‐Min Yuan Woon‐Puay Koh Yechiel Friedlander Tanika N. Kelly Wen Bin Wei Liang Xu Hui Cai Yong‐Bing Xiang Kuang Lin Robert Clarke Robin Walters Iona Y. Millwood Liming Li John C. Chambers Jaspal S. Kooner Paul Elliott Pim van der Harst Marie Loh Niek Verweij Weihua Zhang Benjamin Lehne Irene Mateo Leach Alexander Drong James Abbott Han Sun William R. Scott Gianluca Campanella Marc Chadeau‐Hyam Uzma Afzal Tõnu Esko Sarah E. Harris Jaana Hartiala Marcus E. Kleber Richa Saxena Alexandre F.R. Stewart Tarunveer S. Ahluwalia Imke Aits Alexessander Couto Alves Shikta Das Jemma C. Hopewell Robert W. Koivula Leo‐Pekka Lyytikäinen Iris Postmus Olli Raitakari Robert A. Scott Rossella Sorice

Abstract Blood pressure (BP) is a major risk factor for cardiovascular disease and more than 200 genetic loci associated with BP are known. Here, we perform multi-stage genome-wide association study (max N = 289,038) principally in East Asians meta-analysis Europeans. We report 19 new ancestry-specific variants, conforming to common variant model. At 10 unique loci, distinct non-rare variants colocalize within the same linkage disequilibrium block despite significantly discordant effects...

10.1038/s41467-018-07345-0 article EN cc-by Nature Communications 2018-11-22

Central serous chorioretinopathy (CSC) is a common disease affecting younger people and may lead to vision loss. CSC shares phenotypic overlap with age-related macular degeneration (AMD). As recent studies have revealed characteristic increase of choroidal thickness in CSC, we conducted genome-wide association study on 3,418 individuals followed by TaqMan assays 2,692 subjects, identified two susceptibility loci: CFH rs800292, an established AMD polymorphism, VIPR2 rs3793217 (P = 2.05 ×...

10.1073/pnas.1802212115 article EN cc-by-nc-nd Proceedings of the National Academy of Sciences 2018-05-29

ObjectivesType 2 diabetes is a risk factor for sarcopenia. Evidence on the prevention of sarcopenia using blood glucose–lowering therapy limited. We aimed to examine relationship between changes in glycemic control and effect antidiabetic agents against patients with type diabetes.DesignWe conducted an observational longitudinal study.Setting ParticipantsIn total, 588 Japanese ongoing multicenter study completed 1-year follow-up measurements clinical data.MethodsThe data set Multicenter...

10.1016/j.jamda.2020.11.003 article EN cc-by-nc-nd Journal of the American Medical Directors Association 2020-12-02
Coming Soon ...